Some new chemotherapeutic agents and combinations possibly available for new adjuvant therapies of minimal disease.
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000145:classification / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D050257:Tubulin Modulators
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D050257:Tubulin Modulators; D004317:Doxorubicin; D008727:Methotrexate